-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Statera Biopharma, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2021 to Q1 2022.
- Statera Biopharma, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2022 was $114K.
- Statera Biopharma, Inc. annual Amortization of Intangible Assets for 2021 was $233K.
- Statera Biopharma, Inc. annual Amortization of Intangible Assets for 2020 was $0.000.
- Statera Biopharma, Inc. annual Amortization of Intangible Assets for 2011 was $13.1K, a 26.3% decline from 2010.